SEC Form 4 · accession 0001209191-18-006215
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd Christopher Longsworth
Officer — General Counsel
Period of report
Jan 29, 2018
Accepted (ET)
Jan 31, 2018 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 29, 2018 | M | 11,630 | $6.72 | A | 16,628 | D | |
| Ordinary SharesF1 | Jan 29, 2018 | S | 11,630 | $24.00 | D | 4,998 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF2 | $6.72 | Jan 29, 2018 | M | 11,630 | D | — | Apr 29, 2022 | Ordinary Shares | 82,782 | 71,152 | D |
Explanation of responses
- F1These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth.
- F2Fully vested and exercisable as of the date hereof.